Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - AbCellera Biologics (NASDAQ:ABCL), American Rebel Holdings (NASDAQ:AREB)
AbCellera BiologicsAbCellera Biologics(US:ABCL) Benzinga·2026-02-25 17:22

公司财务业绩 - 公司第四季度营收为7.9672亿美元，超出分析师预期的7.554亿美元[1] - 公司第四季度调整后每股收益为2.15美元，超出分析师预期的1.60美元[1] 市场反应 - 公司股价在盘前交易时段上涨16.2%，至514.21美元[1]

Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - AbCellera Biologics (NASDAQ:ABCL), American Rebel Holdings (NASDAQ:AREB) - Reportify